Biopharmas raising money in public or private financings, including: Aavantgarde, Acurx, Addex, Aerovate, Alia, Antheia, Bioasis, Borea, Cerevel, Giiant, Intellia, Kiromic, Novalis, Numab, Panbela, Sofinnova, Vaxthera.